Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Biotron Limited ( (AU:BIT) ) has issued an announcement.
Biotron Limited has announced a Share Purchase Plan (SPP) allowing eligible shareholders in Australia and New Zealand to purchase new shares at $0.01 each, raising funds to support ongoing operations and strategic partnerships. The funds will also bolster the company’s intellectual property and progress its early-stage Hepatitis B programs, with a minimum target to raise $500,000, below which the company may contemplate administration or closure.
More about Biotron Limited
Biotron Limited is a biotechnology company focused on developing antiviral programs, including its lead clinical asset BIT225. The company is engaged in creating partnerships in the pharmaceutical industry, particularly targeting infectious disease treatments. Biotron emphasizes strong intellectual property to maintain a competitive edge in the market.
YTD Price Performance: 390.0%
Average Trading Volume: 23,250
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $5.71M
For an in-depth examination of BIT stock, go to TipRanks’ Stock Analysis page.